anhedonia < animal < animals

Facettes :

List of bibliographic references indexed by animal

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]

Ident.	Authors (with country if any)	Title
000075 (2017)	Fábio G. Teixeira [Portugal] ; Miguel M. Carvalho [Portugal] ; Krishna M. Panchalingam [Canada] ; Ana J. Rodrigues [Portugal] ; Bárbara Mendes-Pinheiro [Portugal] ; Sandra Anjo [Portugal] ; Bruno Manadas [Portugal] ; Leo A. Behie [Canada] ; Nuno Sousa [Portugal] ; Ant Nio J. Salgado [Portugal]	Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.
000138 (2016)	Naomi P. Visanji [Canada] ; Jonathan M. Brotchie [Canada] ; Lorraine V. Kalia [Canada] ; James B. Koprich [Canada] ; Anurag Tandon [Canada] ; Joel C. Watts [Canada] ; Anthony E. Lang [Canada]	α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era.
000349 (2016)	Vincent Picher-Martel ; Paul N. Valdmanis [États-Unis] ; Peter V. Gould ; Jean-Pierre Julien ; Nicolas Dupré	From animal models to human disease: a genetic approach for personalized medicine in ALS
000774 (2015)	Naomi P. Visanji [Canada] ; Iman Kamali Sarvestani [Canada, Suède] ; Meaghan C. Creed [Canada] ; Zahra Shams Shoaei [Canada] ; José N. Nobrega [Canada] ; Clement Hamani [Canada] ; Lili-Naz Hazrati [Canada]	Deep brain stimulation of the subthalamic nucleus preferentially alters the translational profile of striatopallidal neurons in an animal model of Parkinson's disease
000999 (2014)	Nicolas Morin [Canada] ; Vincent A. Jourdain [Canada] ; Thérèse Di Paolo [Canada]	Modeling dyskinesia in animal models of Parkinson disease.
000B94 (2014)	Nicolas Morin [Canada] ; Vincent A. Jourdain ; Thérèse Di Paolo	Modeling dyskinesia in animal models of Parkinson disease : ANIMAL MODELS OF PARKINSON'S DISEASE
000E09 (2013)	Bo-Rim Yi [Corée du Sud] ; Seung U. Kim [Canada, Corée du Sud] ; Kyung-Chul Choi [Corée du Sud]	Development and application of neural stem cells for treating various human neurological diseases in animal models
001101 (2012)	Francesca Manag [Italie] ; Stefano Espinoza [Italie] ; Ali Salahpour [Canada] ; Tatyana D. Sotnikova [Italie] ; Marc G. Caron [États-Unis] ; Richard T. Premont [États-Unis] ; Raul R. Gainetdinov [Italie, États-Unis]	The role of GRK6 in animal models of Parkinson's Disease and L-DOPA treatment
001514 (2012)	Marie-Anne El Khoury [France] ; Victor Gorgievski [France] ; Larissa Moutsimilli [France] ; Bruno Giros [France, Canada] ; Eleni T. Tzavara [France]	Interactions between the cannabinoid and dopaminergic systems: Evidence from animal studies
001610 (2011)	James B. Koprich ; Tom H. Johnston ; Philippe Huot ; M. Gabriela Reyes ; Maria Espinosa ; Jonathan M. Brotchie	Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
001642 (2011)	Fariborz Rahimi [Canada] ; Marei Typlt ; Mandar S. Jog	Levodopa and Parkinson disease--electrophysiological perspectives in animal models.
001724 (2011)	Shawn Hayley [Canada] ; Emily Mangano [Canada] ; Geoffrey Crowe [Canada] ; Nanqin Li [Canada] ; Wayne J. Bowers [Canada]	An in vivo animal study assessing long-term changes in hypothalamic cytokines following perinatal exposure to a chemical mixture based on Arctic maternal body burden
001738 (2011)	Simon C. Spanswick [Canada] ; Hugo Lehmann [Canada] ; Robert J. Sutherland [Canada]	A Novel Animal Model of Hippocampal Cognitive Deficits, Slow Neurodegeneration, and Neuroregeneration
001915 (2011)	Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada]	Synergistic Antidyskinetic Effects of Topiramate and Amantadine in Animal Models of Parkinson's Disease
001A09 (2010)	R. Andrew Tasker [Canada] ; Amber L. Adams-Marriott [Canada] ; Christopher A. Shaw	New animal models of progressive neurodegeneration: tools for identifying targets in predictive diagnostics and presymptomatic treatment
001A68 (2010)	C. Hamani [Canada] ; J N Nobrega ; A M Lozano	Deep brain stimulation in clinical practice and in animal models.
001C07 (2010)	Catharine A. Winstanley [États-Unis] ; Peter Olausson [États-Unis] ; Jane R. Taylor [États-Unis] ; J. David Jentsch [États-Unis]	Insight Into the Relationship Between Impulsivity and Substance Abuse From Studies Using Animal Models
001C48 (2010)	Clement Hamani [Canada] ; José N. N Brega [Canada]	Deep brain stimulation in clinical trials and animal models of depression
001E50 (2009)	Francesca Cicchetti [Canada] ; Janelle Drouin-Ouellet ; Robert E. Gross	Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?
002079 (2009)	M. Bousquet [Canada] ; C. Gibrat [Canada] ; M. Saint-Pierre [Canada] ; C. Julien [Canada] ; F. Calon [Canada] ; F. Cicchetti [Canada]	Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model
002196 (2008)	Marc Morissette [Canada] ; Sara Al Sweidi ; Sophie Callier ; Thérèse Di Paolo	Estrogen and SERM neuroprotection in animal models of Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "animal" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "animal" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    animal
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022